Aurinia Pharmaceuticals Inc.
AUPH
$15.99
$0.271.72%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 47.17% | 14,651.15% | 119.87% | 2,879.64% | 317.17% |
| Total Depreciation and Amortization | -0.82% | 0.04% | -0.57% | 0.43% | 0.19% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 424.53% | -13,241.18% | -55.76% | 136.08% | 0.36% |
| Change in Net Operating Assets | 48.47% | -71.10% | 134.77% | 11.49% | -132.06% |
| Cash from Operations | 2,404.62% | 51.65% | 161.02% | 179.25% | 106.99% |
| Capital Expenditure | -129.41% | 74.38% | -146.43% | 23.44% | -41.67% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -158.10% | -192.86% | -27.96% | 65.77% | -36.95% |
| Cash from Investing | -158.26% | -193.71% | -30.27% | 65.63% | -36.97% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -31.83% | -15.08% | -16.57% | -6.42% | 0.25% |
| Issuance of Common Stock | -92.32% | -3.35% | 394.54% | 29.70% | 68.14% |
| Repurchase of Common Stock | 9.15% | 98.35% | -5,310.18% | -570.55% | -213.84% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -8.81% | 91.80% | -285.38% | -436.61% | -227.80% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -130.55% | -84.83% | 440.48% | 56.76% | -209.12% |